Completed

A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)

I3Y-MC-JPBJ - ClinicalTrials.gov - NCT02079636

The main purpose of this study is to evaluate the safety and tolerability of abemaciclib in combination with another anti-cancer drug in participants with NSCLC that is advanced or has spread to other parts of the body (stage IV). The study will also investigate how the body processes the combination treatment and how the study drug affects the body. The study will also collect disease-related symptoms and participant-reported pain related to NSCLC.
How long will I be in the trial?
Depending on how you and your tumor respond to treatment, your study participation could last until your disease worsens or until you and your doctor decide to stop treatment.
Email
Completed

A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)

I3Y-MC-JPBJ - ClinicalTrials.gov - NCT02079636

The main purpose of this study is to evaluate the safety and tolerability of abemaciclib in combination with another anti-cancer drug in participants with NSCLC that is advanced or has spread to other parts of the body (stage IV). The study will also investigate how the body processes the combination treatment and how the study drug affects the body. The study will also collect disease-related symptoms and participant-reported pain related to NSCLC.
How long will I be in the trial?
Depending on how you and your tumor respond to treatment, your study participation could last until your disease worsens or until you and your doctor decide to stop treatment.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Non-small Cell Lung Cancer

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

150

Trial Dates

March 2014 - August 2019

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Non-small Cell Lung Cancer

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

150

Trial Dates

March 2014 - August 2019

Trial Phase

1

Not the right fit? Sign up to receive updates on new Non-small Cell Lung Cancer trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Non-small Cell Lung Cancer Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?